SCHEMBL3362001

SCHEMBL3362001

[CH2]c1cc(=O)[nH]c(=O)[nH]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11726927 0.67 CA1 (0.44) —
SCHEMBL1673294 0.67 — —
SCHEMBL325682 0.67 — —
SCHEMBL317622 0.67 — —
SCHEMBL13918178 0.67 — —
SCHEMBL8188652 0.67 — —
SCHEMBL1896344 0.67 — —
SCHEMBL1774205 0.67 — —
SCHEMBL60308 0.67 — —
Hydrochloric Acid SCHEMBL30618396 0.65 CA1 (0.95) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220177521-A1 PROCESS FOR THE PREPARATION OF DEGARELIX Fresenius Kabi Ipsum S.R.L. (IT) 2022-06-09 — — US claimed
EP-3935072-A1 PROCESS FOR THE PREPARATION OF DEGARELIX Fresenius Kabi iPSUM S.r.l. (IT) 2022-01-12 — — EP claimed
US-6359061-B1 COMBINATORIAL LIBRARIES ARE USEFUL FOR SCREENING IN BIOLOGCAL ASSAYS IN ORDER TO IDENTIFY PHARMACEUTICALLY USEFUL COMPOUNDS ISIS PHARMACEUTICALS, INC. 2002-03-19 — — US claimed
US-6316623-B1 USEFUL FOR SCREENING IN BIOLOGICAL ASSAYS IN ORDER TO IDENTIFY PHARMACEUTICALLY USEFUL COMPOUNDS ISIS PHARMACEUTICALS, INC. 2001-11-13 — — US claimed
US-5395838-A Aromatic aminomethyl substitutes compounds IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1995-03-07 — — US claimed
EP-0373891-B1 Anti-tumour agents ICI PLC (GB) 1994-11-02 — — EP claimed
EP-0373891-A2 Anti-tumour agents IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1990-06-20 — — EP claimed
US-4386073-A ANTIDOTES TO EFFECTS OF CERTAIN DRUGS PATENTBUREAU DANUBIA (HU) 1983-05-31 — — US claimed
US-3944550-A Vitamin E orotate and a method of producing the same KANEBO LTD. (JA) 1976-03-16 — — US claimed
CN-116327957-A Combination of agonist anti-PD-1 antibodies with GnRH agonists or GnRH antagonists for the treatment of cancer 德彪药业国际股份公司 2023-06-27 — — CN disclosed
CN-111727060-B Agonist anti-PD-1 antibodies in combination with GnRH agonists or GnRH antagonists for the treatment of cancer 德彪药业国际股份公司 2023-04-11 — — CN disclosed
US-20220177521-A1 PROCESS FOR THE PREPARATION OF DEGARELIX Fresenius Kabi Ipsum S.R.L. (IT) 2022-06-09 — — US disclosed
EP-3935072-A1 PROCESS FOR THE PREPARATION OF DEGARELIX Fresenius Kabi iPSUM S.r.l. (IT) 2022-01-12 — — EP disclosed
CN-111727060-A Agonist anti-PD-1 antibodies in combination with GnRH agonists or GnRH antagonists for the treatment of cancer 德彪药业国际股份公司 2020-09-29 — — CN disclosed
EP-0373891-A2 Anti-tumour agents IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1990-06-20 — — EP disclosed
US-4725581-A NERVOUS SYSTEM DISORDERS, COGNITION ACTIVATORS ADIR ET COMPAGNIE (FR) 1988-02-16 — — US disclosed
EP-0217688-A1 Peptide derivatives with a lactonic or cycloamidic structure, process for their preparation and pharmaceutical compositions containing them ADIR ET COMPAGNIE (FR) 1987-04-08 — — EP disclosed
US-4386073-A ANTIDOTES TO EFFECTS OF CERTAIN DRUGS PATENTBUREAU DANUBIA (HU) 1983-05-31 — — US disclosed
US-4386073-A ANTIDOTES TO EFFECTS OF CERTAIN DRUGS PATENTBUREAU DANUBIA (HU) 1983-05-31 — — US disclosed
US-3944550-A Vitamin E orotate and a method of producing the same KANEBO LTD. (JA) 1976-03-16 — — US disclosed
Send feedback